Literature DB >> 8512345

Expression of epidermal growth factor receptor (proto-oncogene c-erbB-1) and estrogen receptor in human breast carcinoma. An immunocytochemical study of 70 cases.

C Garcìa Castro1, M Ravina, V Castro, E C Salido.   

Abstract

In vitro studies have shown that growth factors may mediate the growth stimulatory effect of estrogen in hormone-dependent human breast carcinomas while the constitutive expression of same growth factors might by-pass the need for estrogenic stimulus in hormone-independent neoplasms. We have performed immunocytochemical analysis of the expression of epidermal growth factor receptor (EGF-R or proto-oncogen c-erbB-1) and estrogen receptor (ER) in 70 cases of human breast carcinoma. We found an inverse relationship between the expression of EGF-R and ER (Kendall's tau b = -0.1997, P < 0.03), which prompts us to conclude that ER(-) breast carcinomas may grow in a hormone-independent manner through the over-expression of the proto-oncogene c-erbB-1, which is the receptor for epidermal (EGF) and alpha transforming (TGFalfa) growth factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512345     DOI: 10.1007/BF02426354

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  38 in total

Review 1.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

2.  Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer.

Authors:  R A McClelland; U Berger; L S Miller; T J Powles; E V Jensen; R C Coombes
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 3.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 4.  What's new in oncogenes and growth factors?

Authors:  F Marks
Journal:  Pathol Res Pract       Date:  1987-12       Impact factor: 3.250

5.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

6.  Amplification of the epidermal growth factor receptor gene in the BT20 breast carcinoma cell line.

Authors:  J Lebeau; G Goubin
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

7.  Receptors for epidermal growth factor and estradiol in canine mammary tumors.

Authors:  V R Nerurkar; R Seshadri; R Mulherkar; C S Ishwad; V S Lalitha; S N Naik
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

8.  Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.

Authors:  Y Umekita; N Enokizono; Y Sagara; K Kuriwaki; T Takasaki; A Yoshida; H Yoshida
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.

Authors:  G Carpenter; C M Stoscheck; Y A Preston; J E DeLarco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.

Authors:  Y Mizukami; A Nonomura; T Yamada; H Kurumaya; M Hayashi; N Koyasaki; T Taniya; M Noguchi; S Nakamura; F Matsubara
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

View more
  4 in total

Review 1.  EGFR signaling in breast cancer: bad to the bone.

Authors:  John Foley; Nicole K Nickerson; Seungyoon Nam; Kah Tan Allen; Jennifer L Gilmore; Kenneth P Nephew; David J Riese
Journal:  Semin Cell Dev Biol       Date:  2010-09-09       Impact factor: 7.727

2.  Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Richard N Baumgartner; Kathy B Baumgartner; Christina M Pinkston; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2013-11-28

3.  Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.

Authors:  Georgios Lazaridis; Sofia Lambaki; Georgia Karayannopoulou; Anastasia G Eleftheraki; Irene Papaspirou; Mattheos Bobos; Ioannis Efstratiou; George Pentheroudakis; Nikolaos Zamboglou; George Fountzilas
Journal:  Strahlenther Onkol       Date:  2014-07       Impact factor: 3.621

4.  Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.

Authors:  S Samanta; V M Sharma; A Khan; A M Mercurio
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.